GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosyntech Inc (OTCPK:BSYI) » Definitions » FCF Margin %
中文

Biosyntech (Biosyntech) FCF Margin %

: -147,700.00% (As of Dec. 2009)
View and export this data going back to 2000. Start your Free Trial

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Biosyntech's Free Cash Flow for the three months ended in Dec. 2009 was $-1.48 Mil. Biosyntech's Revenue for the three months ended in Dec. 2009 was $0.00 Mil. Therefore, Biosyntech's FCF Margin % for the quarter that ended in Dec. 2009 was -147,700.00%.

As of today, Biosyntech's current FCF Yield % is 0.00%.

The historical rank and industry rank for Biosyntech's FCF Margin % or its related term are showing as below:

BSYI' s FCF Margin % Range Over the Past 10 Years
Min: -3800.55   Med: 0   Max: 0
Current: -3800.55


BSYI's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -148.935 vs BSYI: -3800.55


Biosyntech FCF Margin % Historical Data

The historical data trend for Biosyntech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyntech Annual Data
Trend Mar00 Mar01 Mar02 Mar03 Mar04 Mar05 Mar06 Mar07 Mar08 Mar09
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,212.33 -10,294.44 -3,198.08 -3,106.96 -24,234.38

Biosyntech Quarterly Data
Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -57,675.00 -9,715.79 -3,463.27 -1,659.82 -147,700.00

Competitive Comparison

For the Biotechnology subindustry, Biosyntech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosyntech FCF Margin % Distribution

For the Biotechnology industry and Healthcare sector, Biosyntech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Biosyntech's FCF Margin % falls into.



Biosyntech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Biosyntech's FCF Margin for the fiscal year that ended in Mar. 2009 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2009 )/Revenue (A: Mar. 2009 )
=-7.755/0.032
=-24,234.38 %

Biosyntech's FCF Margin for the quarter that ended in Dec. 2009 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2009 )/Revenue (Q: Dec. 2009 )
=-1.477/0.001
=-147,700.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biosyntech FCF Margin % Related Terms

Thank you for viewing the detailed overview of Biosyntech's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosyntech (Biosyntech) Business Description

Traded in Other Exchanges
N/A
Address
475 Boulevard Armand-Frappier, Laval, QC, CAN, H7V 4B3
Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.

Biosyntech (Biosyntech) Headlines

No Headlines